Abstract BACKGROUND: Cholangiopathies impair the balance between proliferation and apoptosis of cholangiocytes leading to the disappearance of bile ducts and liver failure. Taurocholic acid (TC) is essential for cholangiocyte proliferative and functional response to cholestasis. Bile acids and neurotransmitters co-operatively regulate the biological response of the biliary epithelium to cholestasis. Adrenergic denervation of the liver during cholestasis results in the damage of bile ducts. AIM: To verify whether TC feeding prevents the damage of the biliary tree induced by adrenergic denervation in the course of cholestasis. METHODS: Rats subjected to bile duct ligation (BDL) and to adrenergic denervation were fed a TC-enriched diet,...
Cholestasis is a reduction in bile flow that occurs during numerous pathologies. Cholestasis leads t...
Cholestasis is a pathological condition of reduced bile formation or flow. It arises from hepatocell...
Ursodeoxycholic acid exerts anticholestatic effects in chronic cholestatic liver disease in humans a...
Cholangiopathies, such as primary biliary cirrhosis and primary sclerosis cholangitis, are character...
Abstract: Bile acids are cytoprotective in hepatocytes by activating phosphatidylinositol-3-kinase (...
The aim of this study was to determine whether taurocholate prevents vagotomy-induced cholangiocyte ...
Abstract: Background & Aims: We tested the hypothesis that during bile duct obstruction, increased b...
Cholangiocytes are the target cells in cholestatic models of ductal hyperplasia including bile duct ...
Background: Ischemic injury by hepatic artery ligation (HAL) during obstructive cholestasis induced ...
Accumulating bile acids (BA) trigger cholangiocyte proliferation in chronic cholestasis. The aim of ...
<div><p>Introduction</p><p>Cholestasis is characterized by accumulation of bile acids and inflammati...
Objective: Ursodeoxycholic acid (UDCA) exerts anticholestatic effects in part by protein kinase C (P...
Background/Aims: Taurohyodeoxycholate (THDCA) and tauroursodeoxycholate (TUDCA) induce more bile flo...
Cholestasis is a reduction in bile flow that occurs during numerous pathologies. Cholestasis leads t...
Cholestasis is a pathological condition of reduced bile formation or flow. It arises from hepatocell...
Ursodeoxycholic acid exerts anticholestatic effects in chronic cholestatic liver disease in humans a...
Cholangiopathies, such as primary biliary cirrhosis and primary sclerosis cholangitis, are character...
Abstract: Bile acids are cytoprotective in hepatocytes by activating phosphatidylinositol-3-kinase (...
The aim of this study was to determine whether taurocholate prevents vagotomy-induced cholangiocyte ...
Abstract: Background & Aims: We tested the hypothesis that during bile duct obstruction, increased b...
Cholangiocytes are the target cells in cholestatic models of ductal hyperplasia including bile duct ...
Background: Ischemic injury by hepatic artery ligation (HAL) during obstructive cholestasis induced ...
Accumulating bile acids (BA) trigger cholangiocyte proliferation in chronic cholestasis. The aim of ...
<div><p>Introduction</p><p>Cholestasis is characterized by accumulation of bile acids and inflammati...
Objective: Ursodeoxycholic acid (UDCA) exerts anticholestatic effects in part by protein kinase C (P...
Background/Aims: Taurohyodeoxycholate (THDCA) and tauroursodeoxycholate (TUDCA) induce more bile flo...
Cholestasis is a reduction in bile flow that occurs during numerous pathologies. Cholestasis leads t...
Cholestasis is a pathological condition of reduced bile formation or flow. It arises from hepatocell...
Ursodeoxycholic acid exerts anticholestatic effects in chronic cholestatic liver disease in humans a...